PharmAthene IncAdd to My Watchlist

PIP:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 0.91
  • 0.06  -6.19%
    Today's Change
  • 0.97
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 2/23/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding67 million
Market Cap$61 million
Return on Equity ttm149.06%
Last Dividend$2.91
Dividend Yield ttm319.78
Relative Dividend Yield benchmark--
Dividend Ex-Date2/6/17
Dividend Pay Date2/3/17
EPS: Year Actual ttm0.542
EPS: Year Est. 12/16 ttm--
EPS: Quarterly Actual -- 0.55
EPS: Quarterly Est. -- --
Price/Earnings ttm1.68
Relative Price/Earnings0.077
Earnings Growth Rate70.59
Company Description
PharmAthene, Inc. develops biological and chemical defense products. The Company's services include expertise in infectious diseases and genome science across the spectrum to pharmaceutical marketing and management.
Revenue$11 million
Net Income$-3 million
Total Assets$20 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!